NEJRA TABAKOVIC PA-C
Prescription History 1376281949
Physician Assistant in Clearwater, FL
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for NEJRA TABAKOVIC PA-C, an active Physician Assistant specialist practicing in Clearwater, FL. Our medical registry currently tracks 4 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 59 documented patient claims. Among these therapy options, the most frequently utilized medication is Eliquis, which accounts for 17 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other FL PrescribersVs. FL Avg |
|---|---|---|---|
| EliquisApixaban | 17 | $887.12▼ below FL avg | ▼ Less than typical |
About Eliquis: Apixaban is used to prevent serious blood clots from forming due to a certain irregular heartbeat (atrial fibrillation) or after hip/knee replacement surgery. Show more ▾ With atrial fibrillation, part of the heart does not beat the way it should. This can lead to blood clots forming, which can travel to other parts of your body (such as the lungs or legs) or increase your risk for stroke. In the United States, apixaban is also approved to treat certain types of blood clots (deep vein thrombosis-DVT, pulmonary embolus-PE) and to prevent them from forming again. Apixaban is an anticoagulant that works by blocking certain clotting proteins in your blood. An antithrombotic agent. In 2024, this provider wrote 17 Medicare prescriptions for Eliquis, about a quarter of the volume of the typical Florida prescriber of this medication (84.2). Medicare paid an average of $887.12 per fill, versus $915.40 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average FL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the FL average for this medication. 27 30-Day Fills standardized to 30-day supplies 782 Days of Medication total across all patients in 2024 | |||
| Ondansetron OdtOndansetron | 16 | $14.42▼ below FL avg | ▼ Less than typical |
About Ondansetron Odt: This medication is used alone or with other medications to prevent nausea and vomiting caused by cancer drug treatment (chemotherapy) and radiation therapy. Show more ▾ It is also used to prevent and treat nausea and vomiting after surgery. Ondansetron works by blocking one of the body's natural substances (serotonin) that causes vomiting. A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties. In 2024, this provider wrote 16 Medicare prescriptions for Ondansetron Odt, about 61% of the volume of the typical Florida prescriber of this medication (26.4). Medicare paid an average of $14.42 per fill, versus $18.04 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average FL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the FL average for this medication. 16 30-Day Fills standardized to 30-day supplies 167 Days of Medication total across all patients in 2024 | |||
| Letrozole | 14 | $14.24▼ below FL avg | ▼ Less than typical |
About Letrozole: This medication is used to treat certain types of breast cancer (such as hormone-receptor-positive breast cancer) in women after menopause. Show more ▾ Letrozole is also used to help prevent the cancer from returning. Some breast cancers are made to grow faster by a natural hormone called estrogen. Letrozole decreases the amount of estrogen the body makes and helps to slow or reverse the growth of these breast cancers. A triazole and benzonitrile derivative that is a selective non-steroidal aromatase inhibitor, similar to ANASTROZOLE. It is used in the treatment of metastatic or locally advanced breast cancer in postmenopausal women. In 2024, this provider wrote 14 Medicare prescriptions for Letrozole, about a quarter of the volume of the typical Florida prescriber of this medication (52.6). Medicare paid an average of $14.24 per fill, versus $22.66 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average FL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the FL average for this medication. 42 30-Day Fills standardized to 30-day supplies 1,260 Days of Medication total across all patients in 2024 | |||
| Tamoxifen Citrate | 12 | $45.43 | ▼ Less than typical |
About Tamoxifen Citrate: Tamoxifen is used to treat breast cancer. Show more ▾ It is also used to reduce the chances of breast cancer in high-risk patients. This medication can block the growth of breast cancer. It works by interfering with the effects of estrogen in the breast tissue. One of the SELECTIVE ESTROGEN RECEPTOR MODULATORS with tissue-specific activities. Tamoxifen acts as an anti-estrogen (inhibiting agent) in the mammary tissue, but as an estrogen (stimulating agent) in cholesterol metabolism, bone density, and cell proliferation in the ENDOMETRIUM. In 2024, this provider wrote 12 Medicare prescriptions for Tamoxifen Citrate, about a third of the volume of the typical Florida prescriber of this medication (32). Medicare paid an average of $45.43 per fill, versus $28.24 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average FL prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 32 30-Day Fills standardized to 30-day supplies 960 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for NEJRA TABAKOVIC PA-C is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Physician Assistant prescribing approach at this Clearwater, FL practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among FL prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
